EUVIMEDEUVIMED entdecken
Crossref

Assessing National Trends and Perceived Safety of Off‐Label Ciprofloxacin‐Dexamethasone Use by Pediatric Otolaryngologists

Hemali P Shah iD, Rema Shah iD, Donovan Lockwood, Nan Yang, Tagan Rohrbaugh iD, Michael J Rutter, Sarah E Maurrasse iD

The Laryngoscope · 2024

DOI: 10.1002/lary.31211 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Hemali P Shah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Yale University School of Medicine, New Haven, Connecticut, U.S.A. Hauptthemen laut MEDLINE: Off-Label Use, Dexamethasone, Practice Patterns, Physicians', Ciprofloxacin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Off‐label use of Ciprodex® (ciprofloxacin‐dexamethasone: CPD), an antibiotic‐steroid combination solution, in the airway has been reported by pediatric otolaryngologists with anecdotal success. We examined national trends regarding off‐label CPD use including prevalence, common indications, prescriber patterns, adverse events, and accessibility.

Methods

15‐item cross‐sectional survey was distributed to American Society of Pediatric Otolaryngology members from January–April 2022. Univariate analyses were performed to compare responses for users of off‐label CPD versus non‐users. Ease of access was compared across geographies and practice types using multivariate logistic regressions.

Results

Of the 163 complete responses (26.6% response rate), 156 (95.7%) reported using off‐label CPD. Most common indications for off‐label CPD were tracheal granulation (87.8%, n = 137) and choanal atresia (82.1%, n = 128). Ease of access was significantly increased in the Midwest (OR:18.79, 95%CI:3.63–1.24, p = 0.001) and West (OR:29.92, 95%CI:3.55–682.00, p = 0.006). Ease of access was significantly lower at tertiary referral centers (OR:0.11, 95%CI:0.01–0.64, p = 0.041) and private practices (OR:0.04, 95%CI:0.002–0.33, p = 0.009) compared to academic free‐standing children's hospitals. Two‐thirds of respondents reported feeling “Very Comfortable” with the safety profile of off‐label CPD; 99.4% ( n = 156) felt that the benefits outweighed the risks of off‐label use. Seven respondents (4.5%) reported adverse events (e.g., local allergic reaction, cushingoid symptoms) from off‐label use.

Conclusions

Our findings (26.6% response rate) suggest that off‐label CPD is commonly used by pediatric otolaryngologists, many of whom reported feeling that the benefits of off‐label CPD outweigh the risks. Our results establish a baseline for future efforts to assess the efficacy and safety of off‐label CPD and to improve its accessibility. Level of Evidence V Laryngoscope , 134:2922–2930, 2024

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Off-Label UseDexamethasonePractice Patterns, Physicians'CiprofloxacinOtolaryngologistsHumansCross-Sectional StudiesUnited StatesChildOtolaryngologyAnti-Bacterial AgentsSurveys and QuestionnairesMaleFemaleDrug Combinations

Stichwörter der Autor:innen

Ciprodexaerodigestiveairway surgeryoff‐labelpediatrictracheostomy

Substanzen

DexamethasoneCiprofloxacinAnti-Bacterial AgentsDrug Combinations

Autor:innen und Institutionen

  • Yale University School of Medicine, New Haven, Connecticut, U.S.A.
  • Department of Otolaryngology-Head and Neck Surgery, Medstar Georgetown University Hospital, Washington, DC, U.S.A.
  • Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut, U.S.A.
  • Yale University School of Public Health, New Haven, Connecticut, U.S.A.
  • Division of Pediatric Otolaryngology-Head and Neck Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, U.S.A.
  • Department of Otolaryngology-Head and Neck Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, U.S.A.

ORCID-Profile: Hemali P Shah, Rema Shah, Tagan Rohrbaugh, Sarah E Maurrasse

Zitieren

APA

Shah, H. P., Shah, R., Lockwood, D., Yang, N., Rohrbaugh, T., Rutter, M. J., & Maurrasse, S. E. (2024). Assessing National Trends and Perceived Safety of Off‐Label Ciprofloxacin‐Dexamethasone Use by Pediatric Otolaryngologists. The Laryngoscope. https://doi.org/10.1002/lary.31211

Vancouver

Shah HP, Shah R, Lockwood D, Yang N, Rohrbaugh T, Rutter MJ, et al. Assessing National Trends and Perceived Safety of Off‐Label Ciprofloxacin‐Dexamethasone Use by Pediatric Otolaryngologists. The Laryngoscope. 2024. doi:10.1002/lary.31211

BibTeX
@article{Shah2024,
  author = {Shah, Hemali P and Shah, Rema and Lockwood, Donovan and Yang, Nan and Rohrbaugh, Tagan and Rutter, Michael J and Maurrasse, Sarah E},
  title = {Assessing National Trends and Perceived Safety of Off‐Label Ciprofloxacin‐Dexamethasone Use by Pediatric Otolaryngologists},
  journal = {The Laryngoscope},
  year = {2024},
  doi = {10.1002/lary.31211}
}
Kostenlos starten →